Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS

ClinicalTrials.gov ID: NCT00539006

Public ClinicalTrials.gov record NCT00539006. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Active Comparator, One-Week, Cross-Over, Multicenter Study to Evaluate the Efficacy and Patient Preference of Nasal Spray Characteristics of Once-Daily, Intranasal Administration of 110mcg Fluticasone Furoate Nasal Spray and 200mcg Fluticasone Propionate Nasal Spray in Adult Subjects With Seasonal Allergic Rhinitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this replicate study to FFU105927 is to provide data on subject preference of FFNS as compared with FPNS.

Study identification

NCT ID
NCT00539006
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
377 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2007 (Type not available)
Primary completion
Nov 2007 (Actual)
Completion
Nov 2007 (Actual)
Last update posted
Dec 9, 2016

2007

United States locations

U.S. sites
24
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
GSK Investigational Site Scottsdale Arizona 85251 —
GSK Investigational Site Fresno California 93720 —
GSK Investigational Site Huntington Beach California 92647 —
GSK Investigational Site Long Beach California 90808 —
GSK Investigational Site Mission Viejo California 92691 —
GSK Investigational Site Orange California 92868 —
GSK Investigational Site Miami Florida 33176 —
GSK Investigational Site Baltimore Maryland 21236 —
GSK Investigational Site North Andover Massachusetts 01845 —
GSK Investigational Site Jackson Mississippi 39202 —
GSK Investigational Site Brick New Jersey 8724 —
GSK Investigational Site Skillman New Jersey 08558 —
GSK Investigational Site Rochester New York 14618 —
GSK Investigational Site Raleigh North Carolina 27607 —
GSK Investigational Site Charleston South Carolina 29407 —
GSK Investigational Site Charleston South Carolina 29414 —
GSK Investigational Site Mt. Pleasant South Carolina 29464 —
GSK Investigational Site Johnson City Tennessee 37601 —
GSK Investigational Site Corsicana Texas 75110 —
GSK Investigational Site El Paso Texas 79902 —
GSK Investigational Site Houston Texas 77070 —
GSK Investigational Site Kerrville Texas 78028 —
GSK Investigational Site San Antonio Texas 78229 —
GSK Investigational Site South Burlington Vermont 05403 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00539006, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2016 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00539006 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →